CN1246009C - Medicine for treating benign and malignant tumours - Google Patents
Medicine for treating benign and malignant tumours Download PDFInfo
- Publication number
- CN1246009C CN1246009C CN 200410012770 CN200410012770A CN1246009C CN 1246009 C CN1246009 C CN 1246009C CN 200410012770 CN200410012770 CN 200410012770 CN 200410012770 A CN200410012770 A CN 200410012770A CN 1246009 C CN1246009 C CN 1246009C
- Authority
- CN
- China
- Prior art keywords
- medicine
- present
- treatment
- ganoderma
- raw materials
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a medicine for treating benign and malignant tumors, which is prepared from the raw materials of the following proportion: 20 to 30 wt % of oldenlandia, 1 to 3 wt % of Huxucao, 20 to 30 wt % of barbed stullcap and 2 to 5 wt % of ganoderma. The raw materials can be taken after 500 mls water added to the raw materials is decocted into 100 to 200 mls of water. The present invention comnines the oldenlandia, the Huxucao, the barbed stullcap and the ganoderma so as to obtain the efficiency of cooperation, and has acrid, bitter and cool taste. The present invention has the functions of dispersing swelling, resolving toxin, softening hard masses, dissipating hardness, removing stasis, expelling toxin, clearing heat, eliminating swelling, promoting blood circulation by removing blood stasis, killing cancer cells and reducing or even eliminating tumors, and has favorable effect on treating various benign tumors and malignant tumors except for nasopharyngeal cancer and brain cancer. The present invention has the advantages of simple preparation, no toxic or side effect, short time of taking medicine, and obvious effect.
Description
Technical field
The present invention relates to a kind of medicine for the treatment of optimum and malignant tumor, belong to the field of Chinese medicines.
Background technology
At present, because the pollution of natural environment and the influence of other factor, sickness rate optimum and malignant tumor increases.Malignant tumor is that cancer is a kind of human life's of threat formidable enemy, and the traditional method for the treatment of cancer at present mainly is excision, chemotherapy, radiotherapy and drug treatment.Excision, chemotherapy, radiotherapy have therapeutical effect preferably to early-stage cancer in some, but because above-mentioned Therapeutic Method all has very serious adverse, influence patient's life quality, and very poor to old person and some middle and advanced stage cancer therapeutic effect.Drug treatment comprises Western medicine and Chinese medicine, and Chinese medicine has good curing and auxiliary treatment effect thereof to cancer.But existing drug matching generally surpasses 20 flavors, and what have reaches flavors up to a hundred, and the compatibility complexity is because the interaction between each raw material produces toxic and side effects unavoidably, and increased the cost of medicine.
Summary of the invention
The technical problem to be solved in the present invention is to provide the medicine of the optimum and malignant tumor of a kind of compatibility treatment simple, that have no side effect.
The technical scheme that the present invention solves the problems of the technologies described above is: a kind of medicine for the treatment of optimum and malignant tumor, make by the raw material of following weight parts: Herba Hedyotidis Diffusae 20-30, Medulla Junci 1-3, Herba Scutellariae Barbatae 20-30 and Ganoderma 2-5.
The weight portion of described each raw material is: Herba Hedyotidis Diffusae 25, Medulla Junci 2, Herba Scutellariae Barbatae 25 and Ganoderma 3.
Above-mentioned raw materials is processed into water preparation by Chinese medicine Chang Jiashi conventional method to get final product.
The present invention makes up Herba Hedyotidis Diffusae, tiger's whiskers grass (Medulla Junci), Herba Scutellariae Barbatae and Ganoderma, thereby generation cooperative effect, acrid in the mouth hardship, cold, have that subduing swelling and detoxicating, softening the hard mass are assaulted fortified position, the function of eliminating stagnation toxin expelling, clearing heat for detumescence and promoting blood circulation to remove blood stasis, can kill cancerous cell, dwindle tumor and disappear even, various benign tumors and the malignant tumor except that the nasopharyngeal carcinoma and the brain cancer are had therapeutical effect preferably.Compatibility of the present invention is simple, has no side effect, and medicine time is short, instant effect.
Further specify beneficial effect of the present invention below by experimental example.
The clinical observation of the optimum and malignant tumor of Drug therapy of the present invention
1, physical data
Accept tumor for medical treatment and suffer from common 68 examples, wherein benign tumor is suffered from 22 examples, and malignant tumor is cancer patient's 46 examples, age 2-69 year.
2, diagnostic criteria: by national regular hospital clinical standard diagnostics.
3, Therapeutic Method: oral 3 times of every day, each 100-200ml, 15 days is a course of treatment, logotype 1-12 course of treatment.
4, criterion of therapeutical effect
Recovery from illness: various tumors are after treatment, and benign tumor disappears, and malignant tumor is decreased to disappearance, recidivist not more than 5 years.
Effectively: benign tumor is dwindled, and malignant tumor is dwindled, and disease alleviates, malignant tumor patient.
Invalid: as not reach the improvement standard
5, therapeutic outcome: benign tumor treatment recovery from illness reaches 20 examples, 6 examples that take a turn for the better, and effective percentage is 100%; Malignant tumor 28 examples of fully recovering, 12 examples that take a turn for the better, 6 examples are invalid.(invalid is nasopharyngeal carcinoma and brain cancer patient)
The model case data
Wang Yiqing, the man, 30 years old, ear had peanut grain size benign tumor behind, took for 1 course of treatment after, tumor disappears.
Chen Ajiao, the woman, 28 years old, left breast had the fibroma of an Ovum Columba livia size, and after treating 3 courses of treatment, lump disappears and fully recovers.
Zhou Guanghui, the man, 65 years old, gastroscopy was reported as gastric cancer, and pylorus has 0.8cm, little curved nearly cardia place that 2 * 1.5cm tumor is arranged, take medicine after 2 courses of treatment, gastroscopy, pylorus have the 0.8cm tumor to disappear, and curved nearly cardia place has 2 * 1.5cm tumor to be contracted to 0.6 * 1cm, after obeying 3 courses of treatment again, the complete obiteration of gastroscopy tumor.After continuing to take 3 courses of treatment, have a rest 1 course of treatment, obey 3 courses of treatment again and consolidate, now healthy living reaches 6 years.
Yang Xianqiang, the man, 55 years old, CT examination was diagnosed as pulmonary carcinoma, inferior lobe of right lung 60mm carcinoma, after 2 courses of treatment of taking medicine, the CT examination report, the inferior lobe of right lung carcinoma has narrowed down to 40mm; Take medicine after 2 courses of treatment, CT examination reports that the inferior lobe of right lung carcinoma has narrowed down to 10mm again; Take medicine after 2 courses of treatment, CT examination reports that the inferior lobe of right lung carcinoma disappears again.After continuing to take 3 courses of treatment, have a rest 1 course of treatment, obey 3 courses of treatment again and consolidate, now healthy living reaches 7 years.
Li Yuqin, the woman, 48 years old, uterus 0.6 * 0.8cm carcinoma was checked in the hospital ultrasound diagnosis, after 1 course of treatment of taking medicine, the examination in hospital report has narrowed down to 0.2 * 0.3cm, take 2 courses of treatment again after, examination in hospital, carcinoma is complete obiteration.Take 3 courses of treatment afterwards and consolidate, now 3 years, do not have recurrence.
The specific embodiment
Embodiment 1: Herba Hedyotidis Diffusae 20g, Medulla Junci 1g, Herba Scutellariae Barbatae 20g and Ganoderma 2g are added water 500ml decocted 30-45 minute, can take to 100-200ml.
Embodiment 2: Herba Hedyotidis Diffusae 30g, Medulla Junci 3g, Herba Scutellariae Barbatae 30g and Ganoderma 5g are added water 500ml decocted 30-45 minute, can take to 100-200ml.
Embodiment 3: Herba Hedyotidis Diffusae 25g, Medulla Junci 2g, Herba Scutellariae Barbatae 25g and Ganoderma 3g are added water 500ml decocted 30-45 minute, can take to 100-200ml.
Claims (2)
1, a kind of medicine for the treatment of optimum and malignant tumor is characterized in that described medicine made by the raw material of following weight parts: Herba Hedyotidis Diffusae 20-30, Medulla Junci 1-3, Herba Scutellariae Barbatae 20-30 and Ganoderma 2-5.
2, medicine as claimed in claim 1 is characterized in that the weight portion of described each raw material is: Herba Hedyotidis Diffusae 25, Medulla Junci 2, Herba Scutellariae Barbatae 25 and Ganoderma 3.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200410012770 CN1246009C (en) | 2004-02-25 | 2004-02-25 | Medicine for treating benign and malignant tumours |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200410012770 CN1246009C (en) | 2004-02-25 | 2004-02-25 | Medicine for treating benign and malignant tumours |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1559601A CN1559601A (en) | 2005-01-05 |
| CN1246009C true CN1246009C (en) | 2006-03-22 |
Family
ID=34440082
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200410012770 Expired - Fee Related CN1246009C (en) | 2004-02-25 | 2004-02-25 | Medicine for treating benign and malignant tumours |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1246009C (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108355012A (en) * | 2018-04-18 | 2018-08-03 | 陈茂华 | The Chinese medicine for the treatment of cancer |
| CN108295224A (en) * | 2018-05-04 | 2018-07-20 | 辽宁金砚生物科技股份有限公司 | A kind of Chinese medicine composition for treating cancer |
| CN108785611A (en) * | 2018-08-29 | 2018-11-13 | 张椿 | A kind of Chinese medicine and preparation method for treating tumour |
-
2004
- 2004-02-25 CN CN 200410012770 patent/CN1246009C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1559601A (en) | 2005-01-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101947284B (en) | Traditional Chinese medicinal composition for treating diabetes and preparation method thereof | |
| CN102283867B (en) | Traditional Chinese medicine composition for treating cancer | |
| CN101181529A (en) | Chinese medicine composition for curing tumor and preparation method thereof | |
| CN1246009C (en) | Medicine for treating benign and malignant tumours | |
| CN101590176B (en) | Chinese medicinal preparation for treating esophagus cancer | |
| CN102940808A (en) | Prescription medicine for treating lung cancer and preparation method | |
| CN101549025B (en) | Traditional Chinese medicine for treating cancer | |
| CN1465387A (en) | Chinese medicine preparation for treating carcinoma of esophagus | |
| CN1391949A (en) | Chinese medicine compound preparation for curing pancreatic cancer | |
| CN106822733B (en) | Ointment for treating precancerous lesion of chronic atrophic gastritis and preparation method thereof | |
| CN102114098B (en) | Pharmaceutic preparation for treating cancer and preparation method thereof | |
| CN1966008A (en) | Medicated wine for treating cancer and tumor and method for preparing same | |
| CN103877457A (en) | Chinese medicinal preparation for treating renal calculus and preparation method thereof | |
| CN115192673B (en) | Traditional Chinese medicine composition for treating sarcoidosis and preparation method thereof | |
| CN1166383C (en) | Medicine for treating tumor in digestive tract and its prepn | |
| CN117771334B (en) | Traditional Chinese medicine composition for regulating autophagy and resisting breast tumors and nodules as well as preparation method and application thereof | |
| CN1256976C (en) | Anti-cancer Chinese medicinal composition and its preparing method | |
| CN1788760A (en) | Cancer-treating capsule and its preparation process | |
| CN106344755B (en) | Compound medicine for treating stomach diseases and preparation method thereof | |
| CN1255173C (en) | Medicine for treating cancer | |
| CN1457805A (en) | Chinese medicine preparation for curing eophagus cancer | |
| CN104784567B (en) | A kind of pharmaceutical composition for the treatment of urinary system infection | |
| CN1068522C (en) | Chinese medicine preparation for cancer and its compounding process | |
| CN111420007A (en) | Multi-target cancer cell killing granule and preparation process thereof | |
| CN116115714A (en) | Anti-tumor traditional Chinese medicine composition and preparation method and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20060322 |